/Companies

Risklick

1 known investors

Find your way into Risklick

Sign up to see every warm intro you have to Risklick

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Risklick team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

RiskLick develops Protocol AI, an AI-powered software platform for designing and developing clinical trial protocols and study plans to accelerate drug development timelines. The platform serves pharmaceutical companies and clinical research organizations seeking to reduce time to market and improve protocol quality.

Founders & leadership

SSven
Sven
BBeat
Beat
IIngrid
IngridPhysician

Board

MEMatthias Egger
Matthias EggerProfessor of Epidemiology

Investors · 1

Frequently asked questions

What does Risklick do?
RiskLick develops Protocol AI, an AI-powered software platform for designing and developing clinical trial protocols and study plans to accelerate drug development timelines. The platform serves pharmaceutical companies and clinical research organizations seeking to reduce time to market and improve protocol quality.
Who are Risklick's investors?
Risklick's investors include Debiopharm Innovation Fund.